Score	Score at Baseline	Test-retest Reliability	Concurrent Validity				Clinically important Change
Score	Mean (SD)	ICC in stable subjects (95% CI)	Pearson's correlation between scores				Change in score indicating a clinically important improvement/worsening
HCV-SIQv4	Mean (SD)	ICC in stable subjects (95% CI)	FSS	CES-D	EQ-5D-5L VAS	EQ-5D-5L Index
TSS	13.4 (12.8)	0.84 (0.794, 0.879	-	-	-	-	-8/8
TSS-IS	13.9 (13.2)	0.84 (0.792, 0.877)	0.56^b	0.68^a	-0.64^a	-0.61^a	-8/8
OBSS	12.4 (11.9)	0.85 (0.802, 0.884)	-	-	-	-	-8/8
OBSS-IS	14.6 (13.7)	0.85 (0.804, 0.884)	0.57^b	0.71^a	-0.64^a	-0.62^a	-8/8
CBSS	16.4 (16.5)	0.86 (0.821, 0.886)	0.59^a	0.59^a	-0.61	-0.57^a	-10/10
GBSS	9.2 (12.6)	0.69 (0.620, 0.741)	0.39	0.50	-0.49	-0.48^b	-5/5
PBSS	18.6 (20.6)	0.75 (0.704, 0.795)	0.51	0.74^a	-0.57	-0.57^a	-8/8
NBSS	17.2 (18.0)	0.84 (0.804, 0.868)	0.50	0.64^a	-0.58	-0.57	-8/8
IBSS	11.8 (15.2)	0.60 (0.516, 0.663)	0.26	0.33	-0.33	-0.30	-5/5